The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids

"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.
http://dlvr.it/SJrPHR